|
William Pullman, M.D., Ph.D. has served as our Senior Vice President and Chief Medical Officer since May 2006. From July 2005 to May 2006, he served as Senior Vice President, Exploratory Development at TransForm Pharmaceuticals, where he built and led the clinical group to support product development efforts. From October 2004 to July 2005, Dr. Pullman served as Senior Vice President, Clinical and Exploratory Pharmacology at Sanofi-Aventis, a pharmaceutical company. From April 2004 until October 2004, Dr. Pullman served as Senior Vice President of Clinical Discovery and Human Pharmacology of Aventis, providing scientific leadership in the early clinical development of pharmaceutical products. From July 2001 until April 2004, Dr. Pullman was Vice President of Clinical Discovery and Human Pharmacology of Aventis. From 1995 to 2001, he held numerous positions at Eli Lilly & Company, a pharmaceuticals company, including serving as Medical Leader for the development and regulatory submission of Cialis. Dr. Pullman's industry experience began at Pfizer Inc., a pharmaceutical company, from 1992 to 1995, where he served as a clinical pharmacologist. He is a fellow of the Royal Australian College of Physicians and received his Ph.D. in Immunology from the Australian National University, and M.B., B.S. (M.D. equivalent) from the University of Western Australia. | 